145 related articles for article (PubMed ID: 28009618)
1. Electroconvulsive Therapy Considerations for Transgendered Patients.
Tran BK; O'Donnell SE; Balla A; Adams DC; Grondin LS; Tsai MH
J ECT; 2017 Jun; 33(2):e14-e16. PubMed ID: 28009618
[TBL] [Abstract][Full Text] [Related]
2. Suxamethonium induced prolonged apnea in a patient receiving electroconvulsive therapy.
Waghmare A; Kumar CN; Thirthalli J
Gen Hosp Psychiatry; 2010; 32(4):447.e1-2. PubMed ID: 20633755
[TBL] [Abstract][Full Text] [Related]
3. Rocuronium-sugammadex use in electroconvulsive therapy of patients with pseudocholinesterase enzyme deficiency.
Yuksel E; Sergin D; Tanatti B; Alper I
J Clin Anesth; 2013 Dec; 25(8):680-1. PubMed ID: 24095888
[No Abstract] [Full Text] [Related]
4. Rocuronium antagonized by sugammadex for series of electroconvulsive therapy (ECT) in a patient with pseudocholinesterase deficiency.
Batistaki C; Kesidis K; Apostolaki S; Kostopanagiotou G
J ECT; 2011 Mar; 27(1):e47-8. PubMed ID: 21206368
[TBL] [Abstract][Full Text] [Related]
5. Neuromuscular blocking agents for electroconvulsive therapy: a systematic review.
Mirzakhani H; Welch CA; Eikermann M; Nozari A
Acta Anaesthesiol Scand; 2012 Jan; 56(1):3-16. PubMed ID: 22092267
[TBL] [Abstract][Full Text] [Related]
6. Butyrylcholinesterase gene mutations in patients with prolonged apnea after succinylcholine for electroconvulsive therapy.
Mollerup HM; Gätke MR
Acta Anaesthesiol Scand; 2011 Jan; 55(1):82-6. PubMed ID: 21029050
[TBL] [Abstract][Full Text] [Related]
7. Minimum Effective Doses of Succinylcholine and Rocuronium During Electroconvulsive Therapy: A Prospective, Randomized, Crossover Trial.
Mirzakhani H; Guchelaar HJ; Welch CA; Cusin C; Doran ME; MacDonald TO; Bittner EA; Eikermann M; Nozari A
Anesth Analg; 2016 Sep; 123(3):587-96. PubMed ID: 26967896
[TBL] [Abstract][Full Text] [Related]
8. Pseudocholinesterase deficiency and electroconvulsive therapy.
Williams J; Rosenquist P; Arias L; McCall WV
J ECT; 2007 Sep; 23(3):198-200. PubMed ID: 17805000
[TBL] [Abstract][Full Text] [Related]
9. Bilateral Forearm Fractures During Modified Electroconvulsive Therapy in a Male Patient With a History of Hyperparathyroidism and Elevated Pseudocholinesterase Activity.
Luccarelli J; Fernandez-Robles C; Berg SM; Henry ME
J ECT; 2019 Sep; 35(3):e35-e36. PubMed ID: 31094876
[No Abstract] [Full Text] [Related]
10. Prolonged succinylcholine action during electroconvulsive therapy (ECT) after cytarabine, vincristine, and rituximab chemotherapy.
Bryson EO; Aloysi AS; Perez AM; Popeo D; Kellner CH
J ECT; 2011 Mar; 27(1):e42-3. PubMed ID: 21206375
[TBL] [Abstract][Full Text] [Related]
11. Anesthesia and electroconvulsive therapy: when succinylcholine is contraindicated.
González A; Benavides J; Lema G
J ECT; 2013 Mar; 29(1):75-6. PubMed ID: 23422522
[No Abstract] [Full Text] [Related]
12. Prolonged apnea after ECT in organophosphorus poisoning - the need to redefine norms.
Sasidharan S; Dhillon HS
BMC Psychiatry; 2021 Mar; 21(1):148. PubMed ID: 33691646
[TBL] [Abstract][Full Text] [Related]
13. Methohexital and succinylcholine dosing for electroconvulsive therapy (ECT): actual versus ideal.
Bryson EO; Aloysi AS; Popeo DM; Bodian CA; Pasculli RM; Briggs MC; Kellner CH
J ECT; 2012 Sep; 28(3):e29-30. PubMed ID: 22914634
[TBL] [Abstract][Full Text] [Related]
14. Rocuronium-sugammadex decreases the severity of post-electroconvulsive therapy agitation.
Postaci A; Tiryaki C; Sacan O; Ornek D; Kalyoncu M; Dikmen B
J ECT; 2013 Mar; 29(1):e2-3. PubMed ID: 23422529
[TBL] [Abstract][Full Text] [Related]
15. A cross-over, post-electroconvulsive therapy comparison of clinical recovery from rocuronium versus succinylcholine.
Turkkal DC; Gokmen N; Yildiz A; Iyilikci L; Gokel E; Sagduyu K; Gunerli A
J Clin Anesth; 2008 Dec; 20(8):589-93. PubMed ID: 19100931
[TBL] [Abstract][Full Text] [Related]
16. Electroconvulsive therapy using rocuronium and sugammadex in patient with neuroleptic malignant syndrome.
Saeki N; Kwon R; Migita T; Fukuda H; Hamada H; Kawamoto M
Anaesth Intensive Care; 2011 Jul; 39(4):762-3. PubMed ID: 21823397
[No Abstract] [Full Text] [Related]
17. Rocuronium reversed by sugammadex for electroconvulsive therapy in a patient with prolonged duration of action of succinylcholine.
Visser WA; Ermens AA; De Boer HD; Van Os E
Anaesth Intensive Care; 2011 Nov; 39(6):1153-4. PubMed ID: 22165379
[No Abstract] [Full Text] [Related]
18. Hereditary pseudocholinesterase deficiency discovery after electroconvulsive therapy.
Pradhan BK; van Helmond N; Mitrev LV; Andonakakis AA
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462045
[TBL] [Abstract][Full Text] [Related]
19. Extreme variability in succinylcholine dose for muscle relaxation in electroconvulsive therapy.
Bryson EO; Kellner CH; Li EH; Aloysi AS; Majeske M
Australas Psychiatry; 2018 Aug; 26(4):391-393. PubMed ID: 29504412
[TBL] [Abstract][Full Text] [Related]
20. Pseudocholinesterase hyperactivity with succinylcholine resistance: an unusual cause of difficult intubation.
Yao FS; Savarese JJ
J Clin Anesth; 1997 Jun; 9(4):328-30. PubMed ID: 9195358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
